Clinical Trials Directory

Trials / Sponsors / Silence Therapeutics plc

Silence Therapeutics plc

Industry · 6 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingStudy to Assess SLN124 in Patients With Polycythemia Vera
Polycythemia Vera
Phase 1 / Phase 22023-01-26
CompletedEvaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Di
Cardiovascular Diseases, Atherosclerosis, Lipoprotein(a)
Phase 22022-12-13
CompletedA Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adult
Non-transfusion-dependent Thalassemia, Low Risk Myelodysplastic Syndrome, Very-Low Risk Myelodysplastic Syndrome
Phase 12021-04-14
CompletedStudy to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(
Hyperlipidemias, Dyslipidemias, Elevated Lp(a)
Phase 12020-11-18
CompletedA Phase 1 Study to Evaluate the Safety, Tolerability, PK and PD of SLN124 in Healthy Volunteers
Healthy Volunteers
EARLY_Phase 12020-09-03
WithdrawnStudy in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of
Non-transfusion-dependent Thalassemia, Low Risk Myelodysplastic Syndrome
Phase 12019-08-20